BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3559979)

  • 1. Effect of tyrosine administration on duodenal ulcer induced by cysteamine in the rat.
    Oishi T; Szabo S
    J Pharmacol Exp Ther; 1987 Mar; 240(3):879-82. PubMed ID: 3559979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dopamine-related drugs on duodenal ulcer induced by cysteamine or propionitrile: prevention and aggravation may not be mediated by gastrointestinal secretory changes in the rat.
    Gallagher G; Brown A; Szabo S
    J Pharmacol Exp Ther; 1987 Mar; 240(3):883-9. PubMed ID: 3559980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pentobarbital anesthesia and bile acids on cysteamine-induced duodenal and gastric ulcers in rats.
    Schwedes U; Clémençon GH; Paschke R; Usadel KH
    Scand J Gastroenterol Suppl; 1984; 92():121-4. PubMed ID: 6146197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical changes in tissue catecholamines and serotonin in duodenal ulceration caused by cysteamine or propionitrile in the rat.
    Szabo S; Horner HC; Maull H; Schnoor J; Chiueh CC; Palkovits M
    J Pharmacol Exp Ther; 1987 Mar; 240(3):871-8. PubMed ID: 3559978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of local secretory and motility changes in the pathogenesis of experimental duodenal ulcer.
    Szabo S; Pihan G; Gallagher GT; Brown A
    Scand J Gastroenterol Suppl; 1984; 92():106-11. PubMed ID: 6588493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteamine-induced duodenal ulcer is not site-specific: effect of local modulating factors.
    Adler RS; Nafradi J; Szabo S
    J Exp Pathol; 1985; 2(2):111-22. PubMed ID: 3842391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of gastric and duodenal pH in the cysteamine-induced duodenal ulcer in the rat.
    Kusterer K; Rohr G; Herrmann W; Piplack C; Schwedes U; Usadel KH; Szabo S
    Acta Physiol Hung; 1989; 73(2-3):247-50. PubMed ID: 2596314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor inhibits cysteamine-induced duodenal ulcers.
    Kirkegaard P; Olsen PS; Poulsen SS; Nexø E
    Gastroenterology; 1983 Dec; 85(6):1277-83. PubMed ID: 6605273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.
    Inatomi N; Hirata T; Inada I; Satoh H; Sino A; Maki Y
    Arzneimittelforschung; 1985; 35(10):1553-9. PubMed ID: 4074415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversion of bile and pancreatic secretion in the rat and its effect on cysteamine-induced duodenal and peptic ulcer development under maximal acid secretion.
    Clémençon GH; Fehr HF; Finger J
    Scand J Gastroenterol Suppl; 1984; 92():112-5. PubMed ID: 6588494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of different prostaglandins on cysteamine-induced duodenal ulcer in the rat.
    Náfrádi J; Bálint GA; Varró V
    Acta Physiol Hung; 1984; 64(3-4):339-41. PubMed ID: 6397967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida albicans aggravates duodenal ulcer perforation induced by administration of cysteamine in rats.
    Nakamura T; Yoshida M; Ishikawa H; Kameyama K; Wakabayashi G; Otani Y; Shimazu M; Tanabe M; Kawachi S; Kumai K; Kubota T; Saikawa Y; Sano K; Kitajima M
    J Gastroenterol Hepatol; 2007 May; 22(5):749-56. PubMed ID: 17444866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the involvement of dopamine agonists and antagonists in duodenal ulcer disease.
    Neumeyer JL; Szabo S
    Klin Wochenschr; 1986; 64 Suppl 7():123-7. PubMed ID: 3494157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of verapamil on cysteamine-induced duodenal ulcer in the rat.
    Lee CK; Yim DS; Kim WH
    J Korean Med Sci; 1987 Dec; 2(4):247-53. PubMed ID: 3268182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pirenzepine prevents cysteamine-induced formation of gastroduodenal ulcers and reduction of mesenteric circulation.
    Bernardini MC; Blandizzi C; Morini G; Chiavarini M; Impicciatore M; Del Tacca M
    Arch Int Pharmacodyn Ther; 1989; 302():242-54. PubMed ID: 2636820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of furazolidone on brain monoamines in the treatment of peptic ulcer].
    Huang CW; Zheng ZT
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):195-7, 14. PubMed ID: 2776061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in duodenal mucosal blood flow and mucus glycoprotein content during cysteamine-induced duodenal ulceration in rats.
    Kurebayashi Y; Asano M; Hashizume T; Akashi A
    Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):152-62. PubMed ID: 4051635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of centrally administered losartan on gastric and duodenal ulcers in rats.
    Merai AH; Asad M; Prasad VS
    Pharmacology; 2009; 84(2):93-8. PubMed ID: 19602912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of bile salts in cysteamine-induced duodenal ulcer in the rat and the ulceroprotective property of lysolecithin.
    Clémençon GH; Fehr HF; Finger J
    Scand J Gastroenterol Suppl; 1984; 92():116-20. PubMed ID: 6588495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interrelation between the analgesic and ulcerogenic action of cysteamine].
    Vinogradov VA; Polonskiĭ VM; Siutkin EA; Smagin VG
    Biull Eksp Biol Med; 1984 Nov; 98(11):582-3. PubMed ID: 6509176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.